Article Text

Download PDFPDF
Open access, open data and drug bulletins

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Time may show that 2012 was the year when open-access publishing – long supported, but not enforced, by research funders and institutions – reached its tipping point. In June a working group for the UK government recommended a “clear policy direction to support publication in open access or hybrid journals, funded by article processing charges, as the main vehicle for the publication of research, especially when it is publicly funded”.1 The group's chair, Dame Janet Finch, asserted that “the long term future lies with open access. . .we need to embrace this change and do so in a measured way”.2 Supporting the gradual transition from subscription-based …

View Full Text